Upside: Low

clg

CLG: Circular Economy Player - Recycling Problems, Not Just Waste

Updated 8 Oct 2025

HOLD rating with $3.62 fair value vs $4.10 current price. Operational turnaround story facing execution challenges and competitive pressure in circular economy sector.

View note
chc

CHC: Property Platform Powerhouse - Premium Price, Perfect Storm Brewing

Updated 8 Oct 2025

Charter Hall Group analysis reveals 50% overvaluation with fair value $11.04 vs current $22.01, facing competitive threats and margin compression despite market leadership.

View note
cen

CEN: Renewable Energy Transformer - Power Play or Pipeline Peril?

Updated 8 Oct 2025

Hold rating with $7.80 fair value vs $8.14 current price. 98% renewable portfolio, 20% market share, 8.4% revenue CAGR, but execution risks from $3.1bn concurrent initiatives.

View note
cda

CDA: Defence Tech Darling - Peak Performance, Peak Peril

Updated 8 Oct 2025

STRONG SELL rating with 58% downside to $10.22 fair value. Peak 24.5% EBITDA margins face inevitable compression as technology commoditises.

View note
ccp

CCP: Debt Buying Dynamo - Transformation's Terminal Value Trap

Updated 8 Oct 2025

HOLD rating with $10.31 fair value vs $15.62 current price. Strong market leadership offset by 36% overvaluation and execution risk across multiple strategic initiatives.

View note
cba

CBA: Banking Behemoth - Party's Over, Hangover Begins

Updated 8 Oct 2025

Australia's dominant bank faces cyclical normalisation from peak metrics. Fair value $122.47 vs current $185.00. Quality franchise, challenging outlook.

View note
bvs

BVS: Wealth Management Software - Digital Dreams, Succession Schemes

Updated 8 Oct 2025

Specialised wealth management software provider trading at $2.21 vs $1.53 fair value. Strong business quality (7.6/10) with 19.5% EBITDA margins but facing competitive pressure and CEO succession uncertainty.

View note
brg

BRG: Premium Appliance Powerhouse - When Perfect Execution Still Isn't Enough

Updated 8 Oct 2025

Trading at 30.0x EV/EBITDA (88% premium to peers), fair value $14.50 vs current $36.18 implies 60% downside despite strong operational metrics.

View note
bio

BIO: Probiotics Pioneer - Priced for Perfection, Positioned for Pain

Updated 8 Oct 2025

AVOID rating with fair value $0.229 vs current $0.52. First profitable year achieved but trading at 56.6x EV/EBITDA versus peer median 12.5x.

View note
bga

BGA: Dairy Giant - Spread Too Thin, Margins Melting

Updated 8 Oct 2025

Trading at $5.25 vs $4.65 fair value. EBITDA margins compressing 5.7% to 4.2%. Manufacturing consolidation targeting $30m savings amid private label pressure.

View note
ben

BEN: Regional Banking Transformation - Digital Dreams Meet Margin Reality

Updated 8 Oct 2025

Trading at $12.84 vs fair value $11.23, BEN faces margin compression and transformation execution risks despite Up platform momentum and community banking moat.

View note
bbn

BBN: Baby Retail Leader - Store of the Future or Store of the Past?

Updated 8 Oct 2025

Baby Bunting trades at $2.60 vs fair value $1.56, with 12.1% revenue growth forecast but 5.2/10 business quality score below peers.

View note